Literature DB >> 23333369

Risk factors for incident atrial fibrillation with and without left atrial enlargement in women.

David Conen1, Robert J Glynn, Roopinder K Sandhu, Usha B Tedrow, Christine M Albert.   

Abstract

BACKGROUND: Left atrial (LA) enlargement facilitates induction and/or maintenance of atrial fibrillation (AF). However, little is known about risk factors for AF with normal LA size.
METHODS: We prospectively followed 34713 initially healthy women for incident AF. Information on echocardiographic LA size at first AF diagnosis was abstracted from medical charts during AF confirmation. LA enlargement was defined as LA diameter >40 mm. Using a competing risk approach, we constructed Cox proportional-hazards models to calculate hazard ratios (HR) and 95% confidence intervals (CI) of risk factors for incident AF with and without LA enlargement, respectively.
RESULTS: Among 796 women with incident AF and available LA size, 328 (41%) had LA enlargement. In multivariable competing risk models, the relationship between age and incident AF was stronger in those with (HR 1.12, 95% CI 1.10-1.14) versus without (HR 1.08, 95% CI 1.06-1.09) LA enlargement (p for difference <0.0001). Body weight was associated with AF only in the presence of LA enlargement (HR per 10 kg 1.34, 95% CI 1.26-1.43; versus 1.07, 95% CI 0.998-1.14, p for difference<0.0001). Hypertension and height were significantly associated with AF both in the presence (HR 1.99, 95% CI 1.49-2.65; and HR per 10 cm 1.36, 95% CI 1.13-1.63) and absence (1.55, 1.25-1.92 and 1.29, 1.10-1.50) of LA enlargement (p for difference 0.17 and 0.66, respectively).
CONCLUSIONS: These data suggest that LA enlargement explains much of the increased AF risk associated with obesity and age. In contrast, height and hypertension appear to also influence AF risk through other mechanisms besides LA enlargement.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Hypertension; Left atrium; Obesity; Women

Mesh:

Year:  2013        PMID: 23333369      PMCID: PMC3643987          DOI: 10.1016/j.ijcard.2012.12.060

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  25 in total

1.  Statement on authorship and publishing ethics in the International Journal of Cardiology.

Authors:  Andrew J S Coats; Louise G Shewan
Journal:  Int J Cardiol       Date:  2011-12-15       Impact factor: 4.164

2.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

3.  Baseline characteristics of participants in the Women's Health Study.

Authors:  K M Rexrode; I M Lee; N R Cook; C H Hennekens; J E Buring
Journal:  J Womens Health Gend Based Med       Date:  2000 Jan-Feb

4.  Obesity and the risk of new-onset atrial fibrillation.

Authors:  Thomas J Wang; Helen Parise; Daniel Levy; Ralph B D'Agostino; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

5.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

8.  Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; E J Benjamin; D Levy
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

9.  Methods to evaluate risks for composite end points and their individual components.

Authors:  Robert J Glynn; Bernard Rosner
Journal:  J Clin Epidemiol       Date:  2004-02       Impact factor: 6.437

10.  Left atrial dimensions determined by M-mode echocardiography in black and white older (> or =65 years) adults (The Cardiovascular Health Study).

Authors:  Teri A Manolio; John S Gottdiener; Teresa S M Tsang; Julius M Gardin
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778

View more
  12 in total

1.  Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Lama Ghazi; Monika M Safford; Yulia Khodneva; Wesley T O'Neal; Elsayed Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-06-07

2.  Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.

Authors:  Daniele Pastori; Ivano Mezzaroma; Pasquale Pignatelli; Francesco Violi; Gregory Y H Lip
Journal:  Br J Clin Pharmacol       Date:  2019-01-11       Impact factor: 4.335

3.  Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

Authors:  Björn Zethelius; Soffia Gudbjörnsdottir; Björn Eliasson; Katarina Eeg-Olofsson; Ann-Marie Svensson; Jan Cederholm
Journal:  Diabetologia       Date:  2015-06-19       Impact factor: 10.122

Review 4.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

5.  Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study).

Authors:  Waqas Qureshi; Elsayed Z Soliman; Scott D Solomon; Alvaro Alonso; Dan E Arking; Amil Shah; Deepak K Gupta; Lynne E Wagenknecht; David Herrington
Journal:  Am J Cardiol       Date:  2014-08-18       Impact factor: 2.778

6.  Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database.

Authors:  Pierre Sabouret; Leyla Depret-Bixio; François-Emery Cotte; Pierre Marie; Nabil Bedira; Patrick Blin
Journal:  Clin Res Cardiol       Date:  2014-05-15       Impact factor: 5.460

Review 7.  Sex differences in cardiometabolic disorders.

Authors:  Eva Gerdts; Vera Regitz-Zagrosek
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

8.  Determinants of Left Atrial Volume in Patients with Atrial Fibrillation.

Authors:  Matthias Bossard; Rahel Kreuzmann; Thomas Hochgruber; Philipp Krisai; Andreas J Zimmermann; Stefanie Aeschbacher; Katrin Pumpol; Arnheid Kessel-Schaefer; Frank-Peter Stephan; Nadja Handschin; Christian Sticherling; Stefan Osswald; Beat A Kaufmann; Guillaume Paré; Michael Kühne; David Conen
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

Review 9.  Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Abhijit Sen; Sabrina Schlesinger; Teresa Norat; Imre Janszky; Pål Romundstad; Serena Tonstad; Elio Riboli; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2017-02-13       Impact factor: 8.082

10.  Aerobic Interval Training Prevents Age-Dependent Vulnerability to Atrial Fibrillation in Rodents.

Authors:  Vegard Malmo; Allen Kelly; Karin S Garten; Tomas Stolen; Natale P L Rolim; Ulrik Wisloff; Godfrey Smith; Jan P Loennechen
Journal:  Front Physiol       Date:  2018-03-09       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.